What Researchers Did
Researchers used Japan's national carbon monoxide poisoning registry (COP-J) to analyze which factors at hospital admission best predicted which patients would develop delayed neurological problems, even among those who received HBOT at 2.8 ATA.
What They Found
Low Glasgow Coma Scale (GCS) score on admission was the strongest predictor of delayed neurological sequelae (DNS), with an odds ratio of 0.736 per GCS point (p=0.002). A GCS cutoff of 12 had 81% sensitivity and 77% specificity for predicting DNS, and this held true even in patients who received HBOT.
What This Means for Canadian Patients
Carbon monoxide poisoning is an OHIP-covered indication for HBOT in Ontario. For Canadian emergency physicians treating CO poisoning, this study provides a simple bedside rule: patients arriving with a GCS of 12 or below are at high risk of developing memory and thinking problems weeks later, even after HBOT. These patients need close neurological follow-up after discharge.
Canadian Relevance
Carbon monoxide poisoning is a covered OHIP indication for HBOT in Ontario. This GCS cutoff can guide follow-up planning in Canadian emergency settings.
Study Limitations
This was a retrospective analysis of a registry not designed to answer this specific question, and it was limited to Japanese patients who all received HBOT, so findings may not apply to CO patients who do not receive HBOT.